mission sirna universal negative control (Merck & Co)
Structured Review

Mission Sirna Universal Negative Control, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mission+sirna+universal+negative+control/pmc13039365-71-5-13?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment"
Article Title: Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment
Journal: Cell Death & Disease
doi: 10.1038/s41419-026-08588-2
Figure Legend Snippet: A Diagram scheme of the indirect co-culture of C4BPA siRNA-transfected FAPs with healthy myoblasts. B Relative expression of C4BPA mRNA levels after transfection ( n = 1). C Dot plot showing the differentiation index of myoblasts after being co-cultured with transfected and non-transfected DMD FAPs and healthy FAPs. D Dot plot showing the number of nuclei per myotube of myoblasts after being co-cultured with transfected and non-transfected DMD FAPs and healthy FAPs. E % of myotubes per field measured by MHCII staining after being co-cultured with transfected and non-transfected DMD FAPs and healthy FAPs. F Representative immunostaining of the indirect co-culture system analysed at the end of the differentiation process after FAPs transfection. Data are shown as means ± SD; Statistical significance was set at P < 0.05. ** P < 0.01; *** P < 0.001.
Techniques Used: Co-Culture Assay, Transfection, Expressing, Cell Culture, Staining, Immunostaining
![( A ) Pretreatment of OCI-AML2 with ferrostatin-1 for 1 h [10 µM], followed by treatment with EN219 [1 µM], CCW16 [1 µM], or RSL3 [10 µM] for 6 h and measurement of cell viability by CellTiterGlo. Error bars show the standard deviation of the mean, n = 3 (biological replicates). ( B ) HeLa WT cells were treated either with EN219 [5 µM] or CCW16 [5 µM] for 6 h and analyzed by immunoblotting. The experiment was performed with three biological replicates. Tubulin was used as loading control. ( C ) Quantification of HMOX1 levels shown in ( B ) normalized to tubulin loading control and DMSO control treatment. P values of two-tailed, unpaired Student’s t -tests are indicated; error bars show the standard deviation of the mean, n = 3 (biological replicates). CCW16: p = 0.0102, EN219: p = 0.0018. ( D ) HT-1080 cells stably overexpressing an empty vector or GPX4 WT (GPX4 OE) were treated for 6 h with CCW16/CCW16-based PROTACs [5 µM] or RSL3 as a positive control [1 µM] after treatment with ferrostatin-1 [10 µM] for 1 h. Cell viability was measured by CellTiterGlo. Error bars show the standard deviation of the mean, n = 3 (biological replicates). OE overexpression. .](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5392/pmc12635392/pmc12635392__44319_2025_593_Fig6_HTML.jpg)